Would you look at that. Cotterell Jannette Suzanne is no longer lobbying for Merck Sharp & Dohme (Australia) Pty Limited.
 oliviagoodman  letswinpc  Merck Amazing to read this:  gives me hope for my younger cousin recently diagnosed with‚Ä¶ 
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails. 
History Behind Merck's New Cancer Blockbuster: Keytruda

Very happy to read this article about the great work of Savor Health started by my  friend Susan Bratton 
Greg Abbott is also awesome on Sanctuary City Laws! Not happy about him paying Merck moving into Austin though! Mor‚Ä¶ 
Love this post,  Merck! 
 Merck 's Keytruda trial comes up short in head and neck cancer, but  US_FDA  approval stays via  statnews
After MYSTIC miss, AstraZeneca taps Merck in  8.5B cancer deal | BioPharma Dive 
AstraZeneca and Merck establish strategic oncology collaboration 
Merck Keytruda fails to improve survival in head & neck cancer 
 healthinnovations  pharma  health  stocks  legal
"Renflexis, will be available at about  750 per 100 mg dose"  biosimilars 
AstraZeneca PLC  AZN Seals a  8.5 Billion R&D Cancer Tie-Up With Merck & Co.  Merck 
 MaxBoot That may be in the next edition of the Merck Manual W.H.C.O.D.  But unfortunately will be a pre-existing condition
 SkinnyRepeal There needs to be a congressional investigation on BIG PHARMA. MERCK, PFIZER, JOHNSON & JOHNSON, etc. needs to be tamed.
 AZN,  Merck team up on cancer combos 
New biosimilar to Remicade due to hit market 35% cheaper than its brand competitor.  drugprices 

 Pharmaceuticals TIENAM I.M. : Vial : 500mg : Merck Sharp & Dohme BV :  Revenues  MarketResearchReports  mrx
AstraZeneca, Merck strike key cancer drugs¬†partnership 
UPDATED: AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails and shares plunge  biopharma
AstraZeneca Shares Plummet 16% On Late-stage Trial Failure; Bristol-Myers Shares Fall 6% And Merck Shares Rise 5% |  
 L117AA  selinasorrels spraying began end of WW2
Merck patent weaponised Brucella Mycoplasma
cause of immune insuff‚Ä¶ 
 kshipwhitecat  AngerMonkey Merck says you can DHAV-1 jab early ducklings if susceptible? But probably too late for your little dudes. :/
AstraZeneca's Mystic shortfall is an immuno-oncology shake-up for Bristol-Myers and a bolster for Merck and Roche 
AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY¬†DEAL 
^^ This message brought to you by Merck KGaA.
Up-to- 8.5 billion  Cancer drug development deal for   AstraZeneca and  Merck : 
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to  8.5B 
 Merck basal  insulin drug has been given tentative approval.  PharmaTimes shares more:: 
Poisoning - Merck Manuals Consumer Version 
AstraZeneca, Merck Seal Cancer Drug Development Deal Worth Up to  8.5B - Genetic Engineering & Biotechnology News ‚Ä¶
The Startling History Behind Merck's New Cancer Blockbuster via  forbes 
 jodihicks  merck_jason  PPActionCA  JerryBrownGov  kdeleon  Rendon63rd  HollyJMitchell  PhilTing The thank you is‚Ä¶ 
AstraZeneca PLC Seals a  8.5 Billion R&D Cancer Tie-Up With Merck & Co. 
AZ, Merck link to develop and commercialise cancer drugs 
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 
HIV-AIDS
US Special Virus Program
MAN-MADE US-patent gene-splice
of Merck weaponised Brucella Mycoplasma [causes MS &CFS]
&SHEEP Visna virus
Q2 GDP, Big Oil, Merck, AbbVie, AAL  Air: Investing Action Plan  Merck  ABBV  American  XOM  CVX  investors
Merck accused of stonewalling in mumps vaccine antitrust lawsuit | Article [AMP] | Reuters 
Pharmaceutical sales are much maligned. But no doctor is going to prescribe a drug they've never heard of. Example: Merck's Zontivity
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign
. AstraZenecaUS and  Merck to collaborate on olaparib development 
New combinations on the horizon. PARP and MEK with PD1/PDL1 to be tested in  AstraZeneca and  Merck collaboration 
Merck's Mammen joins Johnson & Johnson to head R&D, freeing Hait to take up new external  
AstraZeneca, Merck Seal Cancer Drug Development Deal Worth Up to  8.5B via  genbio
So 2014 was the last time  LSolomonTweets could write abt Vax Safety and Pharma in the HuffPost?  StopMediaBlackout
 
1 Thompson Scandal 2 Thorsen Scandal 3 US v Merck  CDCwhistleblower
Where did July go? We are coming into a new month and want to remind you to pick up your flea, tick and heartworm... 
:( Former Merck Rep: "Mandatory Vaccination Is For Profit and Not Public Health"??  NOTokay  Science  Math  History 
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims 
business: Astra falters following failed lung-cancer trial, gives way to Merck and Roche in lung-cancer race‚Ä¶ 
Teaming up to create oncology-focused nutrition programs is  powerful! 
 XRIM  MONEY business

Astra falters following failed lung-cancer trial, gives way to Merck and Roche in lung-cancer race ‚Ä¶
I'm so excited to be teaming up with Merck on the herlifeheradventures campaign, which‚Ä¶ 
Astra falters following failed lung-cancer trial, gives way to Merck and Roche in lung-cancer race‚Ä¶ 
business: Astra falters following failed lung-cancer trial, gives way to Merck and Roche in lung-cancer race‚Ä¶ ‚Ä¶ 
business : Astra falters following failed lung-cancer trial, gives way to Merck and Roche in lung-cancer race‚Ä¶ ‚Ä¶‚Ä¶ 
. Merck HIV Inhibitor Treatment Meets Primary Efficacy Endpoint 
 LifeCoach  Women Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign - P... 
Q2 GDP, Big Oil, Merck, AbbVie, American Air: Investing Action Plan  potstock  marijuana  cannabis
Q2 GDP, Big Oil, Merck, AbbVie, American Air: Investing Action Plan 
zerbaxa cmv merck  a good drug for a bad condition 
AstraZeneca and Merck establish strategic oncology collaboration - 
zerbaxa  merck a great drug to prevent CMV in people undergoing solid organ transplantation.
ICYMI:  AZN‚Äôs MYSTIC trial with Imfinzi goes bust, dents shares despite potential  8.5B  Merck Lynparza deal 
Astra Falters, Gives Way to Merck, Roche in Lung-Cancer Race 
IBDinvestors: Q2 GDP, Big Oil, Merck, AbbVie, American Air: Investing Action Plan 
Merck, Samsung Bioepis launch discounted U.S. Remicade alternative  biosimilars 
After MYSTIC miss,  AZN taps  Merck in  8.5B cancer deal 
 XOM Q2 GDP, Big Oil, Merck, AbbVie, American Air: Investing Action Plan 
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks seesawing 
The Startling History Behind Merck's New Cancer Blockbuster 
The pharmaceutical giants agreed a multi-billion-dollar deal to jointly develop key cancer drugs. 
 cervicalcancer: STAT Plus Pharmalittle AstraZeneca inks deal with Merck as a big cancer drug trial bombs 
Astra Falters, Gives Way to Merck, Roche in Lung-Cancer Race (1) 
Initiative via Corning, Merck & Pfizer:‚Ä¶!
 AZN,  Merck have big So SF real estate plans -> AstraZeneca inks  8.4B pact w Merck as key study fails, shares plunge 
AstraZeneca and Merck Establish Strategic Oncology Collaboration | Business Wire 
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to  8.5B | FiercePharma 
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails | Xconomy 
AstraZeneca's Mystic shortfall an immuno-oncology shake-up for Bristol-Myers and a bolster for Merck and Roche | 
Tesaro paid just  7m upfront for rights to Merck's PARP niraparib and  57m in dev/reg milestones for the first indication in 2012
 BusinessNews "How  Merck's new cancer blockbuster almost didn't come to be:  finance  
The history behind Merck's new cancer blockbuster  Keytruda  Forbes 
How the Petya Global Malware Incident Happened to  Nuance, Merck, and Others, and What It Means to HealthCare‚Ä¶ 
AZ & Merck link to develop & commercialise cancer drugs...
 MoHossain  AstraZeneca .  AstraZeneca failure of a closely watched  cancer trial affected  bmsnews  Merck‚Ä¶ 
"AstraZeneca and Merck establish strategic oncology collaboration"  pharma  biotech  medtech
 TheMandyMoore Joining forces with Merck? That's damn shameful! You're helping damaging people...that's your legacy now.
 MubinaKapasi Maam any view on merck and natco pharma ? They can be an out performer in pharma index?
AstraZeneca, Merck strike key cancer drugs partnership via  YahooNews
STAT Plus Pharmalittle AstraZeneca inks deal with Merck as a big cancer drug trial bombs 
AstraZeneca's Lynparza deal with Merck stokes fellow PARP developer Clovis; shares ahead 6%  CLVS  BGNE 
AstraZeneca and Merck Establish Strategic Oncology Collaboration
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to  8.5B - 
 Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails | 
" AstraZeneca‚Äôs inks  8.4B pact with Merck as crucial MYSTIC study fails"  Pharma 
AstraZeneca's Lynparza deal with Merck stokes fellow PARP developer Clovis; shares ahead 6% 
AstraZeneca's Lynparza deal with Merck stokes fellow PARP developer Clovis; shares ahead 6% - 
AstraZeneca's Lynparza deal with Merck stokes fellow PARP developer Clovis; shares ahead 6%  CLVS  BGNE  TSRO
Reasons Wall St research is free...

Merck Unlikely to Buy Tesaro, Clovis After Deal: Credit Suisse

cc:  ReformedBroker
Some of the more notable corporations that enjoy CFR membership include AIG, BP, Citigroup, Goldman Sachs, Google, Merck, Pfizer.
AstraZeneca's Lynparza deal with Merck stokes fellow PARP developer... 
 cancer  cancer STAT Plus Pharmalittle AstraZeneca inks deal with Merck as a big cancer drug trial bombs: A‚Ä¶ 
 drugdiscovery STAT Plus Pharmalittle AstraZeneca inks deal with Merck as a big cancer drug trial bombs: A‚Ä¶  drug
AstraZeneca's Lynparza deal with Merck stokes fellow PARP developer Clovis; shares ahead 6%  CLVS  BGNE
 Merck &  AstraZeneca entering strategic  oncology collaboration  Merck  AstraZeneca‚Ä¶ 
Merk and Samsung Bioepis have begun selling a less expensive alternative version of Remicade in the United... 
 astrazeneca and  merck partner to collaborate on key cancer drug development.  pharma  oncology  drugs  treatment.  
Astra falters, gives way to Merck, Roche in lung-cancer race via  naomikresge  JamesPaton14 
 ekta_batra Maam any idea on Merck ? It can be an out performer in this pharma segment .
 ovariancancer STAT Plus Pharmalittle AstraZeneca inks deal with Merck as a big cancer drug trial bombs: A‚Ä¶ 
 ovariancancer After MYSTIC miss AstraZeneca taps Merck in  8.5B cancer deal: On the heels of its MYSTIC failure‚Ä¶ 
 colorectal STAT Plus Pharmalittle AstraZeneca inks deal with Merck as a big cancer drug trial bombs: A longawaited‚Ä¶ 
 AstraZeneca and Merck  Merck Establish Strategic  Oncology Collaboration 
AstraZeneca and Merck agree to deal to advance cancer therapies 
Teaming up w/ Merck on  HerLifeHerAdventures to share a content series I‚Äôm working on! Visit‚Ä¶ 
 Digital assistants help improve  health outcomes with  amazon Alexa. 
 Merck undercuts  Pfizer on %Remicade  biosimilar price via  BioPharmaDive
AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% and Merck shares rise 5% 
After  MYSTIC miss,  AstraZeneca taps  Merck in  8.5B  cancer deal via  BioPharmaDive
AstraZeneca and Merck establish strategic oncology collaboration: AstraZeneca and Merck‚Ä¶ 
BUZZ-U.S. STOCKS ON THE MOVE-Twitter, Facebook, Merck, F5 Networks 
Need a Lyft coupon code? Here's one for  50 LyftOfferCode OATH >>> Passion for Merck & Co.?
AstraZeneca and Merck establish strategic oncology collaboration  onmedic  ehealth  pharma
 AstraZeneca  Mystic  lungcancer failure  trial is an immuno-  oncology shake-up  Immunotherapy  chemotherapy 
 NHS  
AstraZeneca, Merck & Co. enter cancer drug development deal focused on PARP inhibitor Lynparza 
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to  8.5B:    recalls
TBT to our  GCHD17 - watch our interview of Marc Luy on  HALE 
We're helping women feel better prepared for the adventures that lie ahead: 
 Merck Why would those sentences convince me to follow you?
I'm all for encouraging women to plan ahead so I‚Äôm excited to work w/ Merck on‚Ä¶ 
Pharmaceutical giants agree on a multibillion-dollar deal to jointly develop key cancer drugs 
This picture is hella old üò© tbt to North Merck days... I miss my hair 
Top Research Reports for Facebook, Verizon   Merck 
 Merck I've the interest to get the TICE BCG product in MEX to continue the treatment that began 2 weeks ago & at the hospital is exhausted.
 POTUS  CplBart  aliboo719  ParentAlerte  USMerckProducts  Merck WTF R U kidding ‚ùì 
A one-on-one relationship may thrive now, but connections with... More for Aquarius 
Merck will be hiring 2 Product Managers in Oncology in Kirkland.  At Merck, your ideas, your talent and your experie‚Ä¶
AstraZeneca (AZ) and Merck & Co. sign  8.5 billion oncology deal covering AZ's olaparib and selumetinib 
 ovariancancer AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B: Merck &amp; Co has agreed to‚Ä¶ 
Merck, Celgene go beyond the pill with Savor's  cancer nutrition programs | FiercePharma by‚Ä¶ 
AstraZeneca PLC Seals an  8 5 Billion R&D Cancer Tie-Up With Merck 
Merck Announces Launch of Renflexis, Biosimilar of Remicade:  pharmacy
.  AstraZeneca and  Merck Seal  Cancer Drug Development Deal Worth Up to  8.5B: 
AstraZeneca's Mystic shortfall is an I-O shake-up for Bristol-Myers and a bolster for Merck and Roche 
AstraZeneca's late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks ...  Bristol  UK 
AstraZeneca's Mystic shortfall is an IO shake-up for Bristol-Myers and a bolster for Merck and Roche  Bristol  UK 
Successful Transformations Require A Post-Period Of Reflection for head of  Merck Manufacturing  ISPEorg  PhRMA
 Merck that is your right as an üá∫üá∏. But I believe in freedom & Justice for all. Our country became great bc of it's diversity.üóΩaüÜìüá∫üá∏üëèüëéüôàüôäüôâüëéüëëüë∫
I'm all for encouraging women to plan ahead so I‚Äôm excited to work w/ Merck on  HerLifeHerAdventures. Visit‚Ä¶ 
AstraZeneca losses over  18B in market cap as MYSTIC study tanks, yet signs  8.4B deal with Merck in aftermath 
Shareholder Campaign: Merck 
Bad news, good news:  AZN‚Äôs MYSTIC trial with Imfinzi goes bust;  Merck Lynparza deal worth up to  8.5B 
one of my favorite fashion bloggers has an instagram post sponsored by Merck
Last week was Mad Scientist week! Thanks again to  Merck  for donating simple circuit kits for our students 
UPDATED: AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails and shares plunge - 
We need to shout it out
We need to March
We need to Chant
First Do No Harm
Pharma Amgen Merck J&J Bayer
Bribing corrupt Leinster House
2017
Merck, Pfizer and Corning team up to produce a new pharmaceutical glass packaging that is more resistant to damage. 
 Job  Stellenangebot - Merck Group: Internship (m\/f) Human Resources - Talent Sourcing
Merck will pay AstraZeneca up to  8.5 billion under a deal to develop and commercialise anti-cancer drugs 
The Pivotal Phase 3  KEYNOTE040 Trial with  KEYTRUDA in  HNSCC Did Not Meet Its Primary Endpoint  Merck 
AstraZeneca's trial setback lifts Merck, hurts Bristol-Myers 
Merck KGaA given ‚Ç¨110.00 PT by Goldman Sachs Group, Inc. (The). neutral rating.  Merck  Merck
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign - PR Newswire (press‚Ä¶ 
 BigPharma is now placing major bets in  DigitalHealth - see where:

Most active corporates‚Ä¶ 
Merck & Co     63,91        +3,41%

Wall Street 
Merck Manuals Survey: 88 Percent of Nurse Practitioners Spend at Least Half of Appointment Times on 
The Startling History Behind Merck's New Cancer Blockbuster--excellent write-up.  
Merck's blockbuster Keytruda was once such a low priority that it was shut down and on out-license list via  forbes 
AstraZeneca, Merck strike key cancer drugs partnership 
Pharmalittle: AstraZeneca inks deal with Merck as a big cancer drug trial bombs - STAT via Black Swan Intelligent ‚Ä¶
 colorectal AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B: Merck &amp; Co has agreed to pay‚Ä¶ 
 colorectal After MYSTIC miss AstraZeneca taps Merck in  8.5B cancer deal: On the heels of its MYSTIC failure the‚Ä¶ 
 colorectal AstraZeneca PLC Seals a  8.5 Billion R&D Cancer TieUp With Merck & Co.: Life Sciences Jobs ... 
AstraZeneca, Merck Seal Cancer Drug Development Deal Worth Up to  8.5B 
AstraZeneca shares plummet 16% premarket on late-stage cancer trial failure 
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures.¬†Campaign 
 biotherapeutics After MYSTIC miss AstraZeneca taps Merck in  8.5B cancer deal: On the heels of its MYSTIC failure‚Ä¶ 
 kidoctr  tracifrost1976  Merck  realDonaldTrump  POTUS They need to read this 
Merck & Co., Inc. (Merck) stock rose by 2.12%! Currently priced at 63.14.
Fascinating story!

 CC4OC

The Startling History Behind Merck's New Cancer Blockbuster via  forbes 
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign 
 MImi_TheSound  tracifrost1976  Merck  realDonaldTrump  POTUS I wish it was that simple. They benefit from herd imm‚Ä¶ 
 kidoctr  tracifrost1976  Merck  realDonaldTrump  POTUS They're the ones responsible for new outbreaks of diseases‚Ä¶ 
 kidoctr  tracifrost1976  Merck  realDonaldTrump  POTUS Don't bother arguing w real science cause they don't believ‚Ä¶ 
Even more Thursday reading: Merck and Pfizer Pull PR Coup With Corning Glass Partnership 
Fascinating history of Merck's cancer blockbuster Keytruda by  DShaywitz  forbeshealth  biotech
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks - MarketWatch 
 AZN  Mystic shortfall is an  IO shake-up for  BMY & a bolster for  Merck &  RHHBY  biotech  lungcancer  NSCLC 
 kidoctr  tracifrost1976  Merck  realDonaldTrump  POTUS Especially KIDS
Hedging its bets after MYSTIC fail,  AZN inks  8.5B  oncology deal with  Merck 
 kidoctr  tracifrost1976  Merck  realDonaldTrump  POTUS Some people want to take us back to the Middle Ages when pe‚Ä¶ 
Merck Animal Health: We need a documented working rabies vaccine for all types of foxes in the US. via  Change
SDBN Feed: Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails via SDBN Blog, ... 
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails ‚Äì¬†Xconomy 
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks seesawing .
‚ù§Ô∏èsurfaces Twitter's most shared  digitalHealth content. Seen this? 
 AZ,  Merck link to develop and commercialise  cancer drugs 
Pharmalot.. Pharmalittle.. Good Morning.. AstraZeneca inks deal w/Merck as key trial bombs..  pharma  AZN  Merck
AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% an..  marketwatch  news 
 Merck Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures.... 
I/O drug combo failure in lung cancer; there is still much to learn about immunotherapy combinations. 
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Mye... 
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks seesawing‚Ä¶ 
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck‚Ä¶ ~
 clinicaltrials news AstraZeneca Gets the Bad News - After writing about Merck&8217;s successes so far in immun... 
Merck gets tentative FDA approval for a Lantus follo w-on--Lusduna Nexvue
 pancreatic AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B: Merck &amp; Co has‚Ä¶  cancer
Big I/O News! 
AstraZeneca's Mystic shortfall is an I-O shake-up for Bristol-Myers and a bolster for Merck and Roche‚Ä¶ 
U.S. STOCKS ON THE MOVE-Twitter, Facebook, Merck, F5 Networks 
"Merck Innovators' Club: Pushing true Innovation in Corporations " ansehen  EventbriteDE
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks seesawing The thr‚Ä¶
 biotherapeutics The Keytruda Story: This is a good history of Keytruda the Merck immunooncology blockbuster from‚Ä¶ 
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails  Texas
AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks‚Ä¶ MARKETWATCH
MarketWatch: "AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks seesawing" ‚Ä¶
AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails. Tremelimumab - never made a mark in the I/O space
 News  Financial  Nashville AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and Bristol-Myers,... 
 autoimmune news: The Keytruda Story - This is a good history of Keytruda the Merck immunooncology blockbuster ... 
NP's can be more productive and cut education time by 50%  Liberate_Health
Improve edu outcomes & pat satisfaction 

[Xconomy SD] Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 
AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B 
AstraZeneca Gets the Bad News - After writing about Merck&8217;s successes so far in immunooncology it&8217;s t... 
AstraZeneca and Merck started oncology collaboration - 
If these guys had sold opiates for Merck or GlaxoSmithKline, they'd be called "businessmen" & "entrepreneurs" & it'd be all good.
AstraZeneca's Mystic shortfall is an I-O shake-up for Bristol-Myers and a bolster for Merck and Roche:    recalls
AstraZeneca's Mystic shortfall is an I-O shake-up for Bristol-Myers and a bolster for Merck and Roche - 
The Keytruda Story: This is a good history of Keytruda the Merck immunooncology blockbuster from David Shayvitz.‚Ä¶ 
 cancer  cancer AstraZeneca Gets the Bad News: After writing about Merck&8217;s successes so far in immunooncology‚Ä¶ 
 cancer  cancer The Keytruda Story: This is a good history of Keytruda the Merck immunooncology blockbuster from‚Ä¶ 
 drugdiscovery AstraZeneca Gets the Bad News: After writing about Merck&8217;s successes so far in‚Ä¶  drug
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Cancer Drug Combo Fails  AZN  BMY  Merck
AstraZeneca teams up with Merck to co-develop/co-commercialize cancer med Lynparza  investing  news
AstraZeneca down 15% premarket on failed late-stage study on lung cancer candidate durvalumab; Merck up 5% on improv‚Ä¶
AstraZeneca teams up with Merck to co-develop/co-commercialize cancer med Lynparza 
AstraZeneca, Merck strike key cancer drugs partnership -offers a glimmer of positivity after MYSTIC disappoints  
Merck & Co. Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results 
Philadelphia,  PA - Merck & Co. - Electrician - ALL SHIFTS - Philadelphia PA Job Philadelphia PA US - Electricia... 
Check out our latest news: 
AstraZeneca teams up with Merck to co-develop/co-commercialize cancer med Lynparza  AZN  Merck 
Have you registered to our  biomarkers webinar? Can't attend?Register & receive the recording  Merck  CPathInstitute
. AstraZeneca,  Merck strike key cancer drugs partnership 
Merck & Company, Inc. (NYSE:Merck) Stake Lowered by Sonata Capital Group¬†Inc. 
AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% and Merck s... (
MarketWatch: AstraZeneca shares plummet 16% premarket on late-stage cancer trial failure 
Merck CEO, Frazier: The global collaboration w/  AZ will ‚Äúincrease the possibilities‚Äù for  cancer patients 

 AtMerc‚Ä¶
 AZN  Merck:

AstraZeneca teams up with Merck to co-develop/co-commercialize ‚Ä¶:


Double helping of immuno-oncology today. First, a look at Merck's success in the area: 
AZ's Mystic shortfall is an I-O shakeup for Bristol and a bolster for Merck and Roche:  AZN  BMY  RHHBY
AstraZeneca shares plummet 16% premarket on late-stage cancer trial failure  News  Money  Finance  BreakingNews
AstraZeneca teams up with Merck to co-develop/co-commercialize cancer med Lynparza  premarket  AZN  Merck
UPDATED:  AstraZeneca inks  8.4B pact with  Merck as crucial MYSTIC study fails and shares plunge - 
AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% and Merck shares rise 5%
 hypertension news: REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration 
AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% and Merck‚Ä¶ MARKETWATCH
 multiplesclerosis: AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B 
 AZN,  Merck establish strategic oncology collaboration 
Merck, Samsung Bioepis launch discounted US Remicade alternative 
AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% and‚Ä¶ ‚Üí via  AlertTrade
Details on the  BMY -  Merck  oncology deal: 
 cancer  cancer AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B: Merck &amp; Co has agreed to‚Ä¶ 
AstraZeneca down 15% premarket on failed late-stage study on lung cancer candidate durvalumab; Merck up...  AZN  Merck
<<<
 Ïú†Î¶∞ÏõêÍ¥ëÏ¢ÖÌï©ÏÇ¨ÌöåÎ≥µÏßÄÍ¥Ä  Í≤ÄÏ¶ùÏÇ¨ÏÑ§ÏÇ¨Ïù¥Ìä∏ adult dating site business insurance in seattle  promdress   Merck  
 cervicalcancer: AstraZeneca Merck Seal Cancer Drug Development Deal Worth up to  8.5B 
 Merck & Co. Plans to File  NDA for  HIV Treatment  Doravirine Based on  PhaseIII Results  biospace
German Pharmaceutical company Merck KGaA is 346 years old and has a history of innovation  OTMonth 
AstraZeneca, Merck strike deal to advance cancer treatments 
The Startling History Behind Merck‚Äôs New Cancer Blockbuster 
AstraZeneca down 15% premarket on failed late-stage study on lung cancer candidate durvalumab; Merck up‚Ä¶  AZN  Merck
 emmafriedmann  mikegalsworthy agree, my comment was too tongue in cheek. You don't need Monsanto and Merck writing‚Ä¶ 
The Startling History Behind Merck's New  Cancer Blockbuster Keytruda via  forbes  immunoOncology
REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration 
Merck & Company, Inc.  Merck Shares Sold by Sonata Capital Group Inc. 
 GMOWTF  welovegv  juliaoftoronto  SavorTooth  ScienceAlly Tell me more about Merck killing people w vaccines - I haven't heard about this.
Is this the beginning of a price war?  Merck launches infliximab  biosimilars at 35% discount versus  pfizer 15%

Merck Manuals Survey: 88 Percent of Nurse Practitioners Spend at Least Half of Appointment ... -  GoogleAlerts
UPDATED: AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails and shares plunge
 AZN  Merck  BMY

MERCK & CO INC SHARES UP 5.2 PCT AT  65.00 IN PREMARKET TRADE AFTER ASTRAZENECA'S LUNG CANCER STUDY FAILS
REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration 
Merck shares rise 5% on rival AstraZeneca's late-stage clinical trial failure 
 drugdiscovery REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to‚Ä¶  drug
 cancer  cancer REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to‚Ä¶ 
Merck  Merck +5 pct;  BMY -5 pct in light premarket trade;  AnkurBanerjee17, Sort of understood the connection, I'm b‚Ä¶ 
Merck More Than A Mother Media Award with William Pike,Director Radio Africa Group. Apply for the media awards toda‚Ä¶ 
AstraZeneca receives  1.6B upfront in oncology collaboration with Merck AstraZeneca (AZN) and Merck (Merck)... 
AstraZeneca receives  8.5 Billion from¬†Merck 
 clinicaltrials news REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration 
 ovariancancer REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to‚Ä¶ 
 biotechnology REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to‚Ä¶ 
 Merck REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration... - 
FlexEnable and Merck collaborate to enable novel display shapes using flexible LCDs 
Feels nice when you get to present ur PhD work!  LifeSci_UoB  ParadkarAnant  Bradford_ENG  Merck  PPE-AMRI2017‚Ä¶ 
REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck  Merck--AstraZeneca and Merck‚Ä¶
AstraZeneca and Merck establish strategic oncology collaboration
REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration via BusinessWire
 Merck:

REPEAT/AstraZeneca and Merck Establish Strategic Oncology ‚Ä¶:


Merck and : REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration  
 publichealth news: REPEATAstraZeneca and Merck Establish Strategic Oncology Collaboration 
Merck Foundation at African Union Assembly, African First Ladies Summit  africanunion  assembly  merckfoundation
 AZN tapping  Merck to develop/commercialize Lynparza and selumetinib with Keytruda 
 Merck  Goldman: "We would expect Merck to trade up about 5 pts" ... after  AZN MYSTIC failure
UK‚Äôs drug giant AstraZeneca and US peer Merck strike a multi-billion-dollar deal to jointly develop key cancer drugs

Merck, AstraZeneca to collaborate on cancer¬†med 
AstraZeneca and Merck Sharp and Dohme ally on cancer research 
AZ, Merck link to develop and commercialise cancer drugs  pharma  health
 Merck wins tentative U.S.  FDA approval for  Lusduna via  BSI_social  merckgroup  Merck
AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEAL

Astrazeneca says establish strategic oncology collaboration with Merck 
 Merck  AZN üëçüèªüëèüèªüëèüèªüôåüèª Establish Strategic Oncology Collaboration

Wow... I did not see this coming at all... 
Merck, Celgene go beyond the pill with Savor's cancer nutrition programs 
AstraZeneca receives  1.6B upfront in oncology collaboration with Merck
AstraZeneca & Merck & Co Establish Strategic Oncology Collaboration 
More UK news at [LSUK] 
BRIEF-Astrazeneca says establish strategic oncology collaboration with Merck  
UPDATED: AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails and shares plunge  biotech
 PioneerCampus  DKFZ  BioRNCluster I'm afraid the article mentioned is not about our company but about MSD (Merck Sharp & Dohme).
AstraZeneca and Merck Establish Strategic Oncology Collaboration

Hill-Rom Holdings, Inc.  HRC EPS Estimated At  0.90; Numeric Investors Has Raised Merck & Co  Merck Holding By  33.... 
 AZN: AstraZeneca and Merck (Merck) form strategic oncology collaboration 
AstraZeneca, Merck & Co. enter cancer drug development deal focused on PARP inhibitor Lynparza  AZN  Merck
 AstraZeneca,  Merck strike key cancer drugs partnership

Day 1 of the  GradConnection Returnee Summit. Very interactive between Universities & our China Employers from Delo‚Ä¶ 
 bradloncar  JacobPlieth Kepler:   AZN  Previous PD-(L)1s including Roche‚Äôs Tecentriq and
Merck & Co‚Äôs Keytruda hav‚Ä¶ 
AstraZeneca and Merck Establish Strategic Oncology Collaboration  Merck
Discount dancers: Pfizer's infliximab matching Merck‚Äôs new biosimilar rival via  BioPharmaReport
Soriot defends giving away half of Lynparza revenues to Merck, says Keytruda combo will create more value.  AstraZeneca
 CREATION  odelannoy  AstraZeneca  Merck  Roche AstraZeneca did some great things online at this ASCO - really good response from HCPs!
AZ have unveiled major alliance with Merck on co-dev and co-marketing Lynparza. Soriot says they'll make it bigger than they could alone.
Merck and Pfizer collaborate with Corning 
AZ, Merck link to develop and commercialise cancer drugs - In a bumper news day for AstraZeneca, the firm annou... 
Astrazeneca says establish strategic oncology collaboration with Merck  collaboration  bees 
AstraZeneca, Merck strike key cancer drugs partnership

Pharmaceutical giants AstraZeneca and Merck said on Thursday they had agreed a mult‚Ä¶
AZ, Merck link to develop and commercialise cancer drugs - 
AstraZeneca and Merck Establish Strategic Oncology Collaboration: KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck‚Ä¶ 
 AstraZeneca and  Merck Establish Strategic Oncology Collaboration (PARP & MEK Inhibitors in Combo with PD-L1/PD-1)

BRIEF-Astrazeneca says establish strategic oncology collaboration with Merck: * ASTRAZENECA‚Ä¶ 
That's one of four announcements on the RNS so far today for  AZN, including oncology deal with Merck. It's in surv‚Ä¶ 
AZN with Merck to develop Lynparza & Selumetinib - AZN could get up to  8.5bn if milestones reached.AZN get   1.6bn upfront + ¬£750m Licence
AstraZeneca tanks 15% after disappointing lung cancer trial result, overshadowing solid first half + new Merck deal 
 clinicalapprovals : AstraZeneca and Merck Establish Strategic Oncology Collaboration 
AstraZeneca, Merck strike key cancer drugs partnership
       

BRIEF-Astrazeneca says establish strategic oncology collaboration with Merck 
AstraZeneca and Merck Establish Strategic Oncology Collaboration: KENILWORTH, N.J‚Ä¶ 
AstraZeneca and Merck Establish Strategic Oncology Collaboration 
AstraZeneca, Merck strike key cancer drugs partnership  DSNHealth  medications
"AZ, Merck link to develop and commercialise cancer drugs"  pharma  biotech  bigpharma  medtech
J&J's Remicade now has two competitors. Will that finally drive down drug prices?

 biosimilars  
 Antony_SW11  marben100  mattbird55  DianaEPatterson  Financial_Orbit  AstraZeneca  JohnCendpts  jimmhk  asibiza1‚Ä¶ 
The  immunotherapy mystery deepens

Keytruda missed its goal in a head & neck cancer trial‚Äîunlike Opdivo last year

 
 vexx_art  vexx_art I wanna start one too. May I suggest the name VErch. Cuz Merck and vexx. Yeah. Also I commented‚Ä¶ 
Crystal structures of agonist-bound human cannabinoid receptor CB1 |  scoopit 
 AstraZeneca,  Merck strike key cancer drugs partnership 
AstraZeneca results in line as new partnership struck with Merck, Mystic disappoints 
I loved working with the Merck team in Vienna. Passionate and creative üëçüèªüëçüèª 
Antibody-drug conjugates manufacturing -bioconjugation, production of payload, linker and mAbs - No... |  scoopit 
A great development for cancer treatment originating from  sheffielduni and  yorkshirecancer research 
 Dow  stocks  Merck Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  
Advancing Monoclonal Antibody Selection |  scoopit 
Merck, Pfizer‚Äôs avelumab clears first hurdle in early access scheme - PharmaTimes 
 clinicaltrials news AstraZeneca and Merck Establish Strategic Oncology Collaboration 
Merck announces positive results from phase 3 study of non-nucleoside reverse transcriptase inhibitor.........  
Revenues slide at AstraZeneca as it announces partnership with Merck 
As part today's deal  Merck to pay  AstraZeneca up to  8.5b inc  1.6bn upfront &  750M for certain license options; balance milestone linked
 publichealth news: AstraZeneca and Merck Establish Strategic Oncology Collaboration 
 ovariancancer AstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to Maximize the‚Ä¶ 
 drugdiscovery AstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to‚Ä¶  drug
 cancer  cancer AstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to Maximize‚Ä¶ 
 biotechnology AstraZeneca and Merck Establish Strategic Oncology Collaboration: Collaboration Aims to Maximize the‚Ä¶ 
 pharma giants  Merck &  AstraZeneca ink collaboration to maximise potential of PARP & MEK inhibitors in combo w/ PD-L1/PD-1 compounds  IO
AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails in first-line lung cancer
 AZN  Merck

 lungcancer news: AstraZeneca and Merck Establish Strategic Oncology Collaboration 
 Merck AstraZeneca and Merck Establish Strategic Oncology Collaboration 
AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEAL 
 hypertension news: AstraZeneca and Merck Establish Strategic Oncology Collaboration 
Click here for our latest news: 
 Merck AstraZeneca and Merck Establish Strategic Oncology Collaboration... - 
AstraZeneca and Merck Establish Strategic Oncology Collaboration KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck  Merck--AstraZeneca and Merck Establ‚Ä¶
AstraZeneca and Merck Establish Strategic Oncology Collaboration via BusinessWire
 Merck:

AstraZeneca and Merck Establish Strategic Oncology Collaboration:


Merck and : AstraZeneca and Merck Establish Strategic Oncology Collaboration  
Merck announces positive results from phase 3 study of non‚îÄnucleoside reverse transcriptase inhibitor, d ... - 
The Startling History Behind Merck's New Cancer Blockbuster - The success of Merck‚Äôs blockbuster cancer drug pe... 
 MerckFertilityTips: Avoid industrial and environmental toxins such as pesticides and heavy metals found in fish an‚Ä¶ 
Nice to read!: The Startling History Behind Merck's New Cancer Blockbuster  keytruda |  forbes 
Success is ultimately dependent upon people: The Startling History Behind  Merck's New Cancer Blockbuster 
Trading places with  Bristol-Myers  Merck hit with another late-stage setback
 PharmaCompass

Introduction to Gastritis and Peptic Ulcer Disease - Digestive Disorders - Merck Manuals Consumer Version 
Brandy Vaughan, Ex Merck Rep:  Vaccines Are the ONLY Product in US that Has No Liability

On the occasion of the Golden Jubilee of Merck‚Äôs incorporation in India, Dr Stefan Oschmann, CEO,  merckgroup, visi‚Ä¶ 
The court took the victims of the years of supervised allegations emerged from the vehicle by the Merck.
Former Merck Employee Targeted After Speaking out Against Forced Vaccina... via  YouTube
I liked a  YouTube video Former Merck Employee Targeted After Speaking out Against Forced Vaccinations
I had the opportunity to work with _lada_merck_  a couple weeks not only is she an excellent‚Ä¶ 
An initiative via Corning,Merck & ; Replace!
Taking the edge of....on a hump day. 
The Startling History Behind Merck's New Cancer Blockbuster by  DShaywitz via  forbes 
Merck Announces U.S. FDA Grants Tentative Approval for Lusduna Nexvue (insulin glargine injection)...........  
MUST SEE: Dr Humphries Examines Data on  Gardasil From Merck's Own Package Insert

 VAXXED 
 Merck You my dear Mercy are a major PROBLEM in US healthcare. You are greedy bastards.  greedybastards  robynlbowman
 UCSF  deray You can't be against mentally ill owning and accessing guns on streets and be okay with mentally ill t‚Ä¶ 
The Startling History Behind Merck's New Cancer Blockbuster.                        
 Merck_Australia working for better outcomes for people with Head and Neck cancer on  WhNCDay2017 
Merck Sued In Philly Over Shingles Vaccine Injuries ‚Äì 
Merck, Celgene go beyond the pill with Savor's  Cancer nutrition programs 
The Startling History Behind Merck & Co.'s New Cancer Blockbuster 
Merck‚Äôs Keytruda fails to improve survival in phase 3 head and neck cancer trial 
Merck, Samsung Bioepis launch discounted U.S. Remicade alternative. 
 News The Startling History Behind Merck's New Cancer Blockbuster 
Overview of Food Poisoning - Injuries and Poisoning - Merck Manuals Consumer Version 
 Merck Friday&apos;s Earnings Reports To Watch: XOM, CVX, Merck, ABBV 
Calling time on the immunotherapy gold rush  AZN  Merck  JUNO  KITE  BLUE 
Soothsayer"  BMY  Merck  AZN- poor clinical trial design shakes PD1  DRG  from weak hands - those with balls will make     "
AstraZeneca PLC  AZN Seals a  8.5 Billion R&D Cancer Tie-Up With Merck & Co.  Merck 
Friday's Earnings Reports To Watch: XOM, CVX, Merck, ABBV  XOM  CVX  Merck  ABBV
 Merck Bull Reversal coming out of Oversold conditions 


 AZN,  Merck team up on cancer combos 
Largest gainers today 7/27/2017 on my Watch List were:  TRN  SBUX  FB  Merck  HOG - 
Did the Checkpoint Inhibitor Bubble Just Burst?  themotleyfool  stocks  Merck,  BMY,  AGEN,  AZN 
5 things for  pharma  marketers to know: Thu., July 27  FDA  GSK  hiv  oncology  AZN  Merck  LLY‚Ä¶ 
Scan results - MACD Bullish Signal Line Cross today:  LPSN  GGG  ICLR  TCF  SCI  MMSI  SNN  Merck  EME  NTCT ... 
Scan results - Stochastic Buy Signal today:  GGG  Merck  EME  ALLE  DRI  ASB  UNP  UA  ATGE  GPI ... 
AstraZeneca Fell 15% Today  AZN  BMY  Merck  PFE
Dynavax: Looking Ahead To A Long and Tiring Journey  GSK  Merck  DVAX  Investing  Stocks
SELL  MA 128.85, SHORT  MCK 162.58, SHORT  MMC 77.41, COVER  Merck 63.73. More stock tips & details at: 
Dynavax: Looking Ahead To A Long and Tiring Journey  GSK  Merck  DVAX
Top  moneyflow for  sp500 today
 NVDA  AMZN  NFLX  BoeingC  P&G  AMD  GOOG  DOW  Merck  BMY ...

AstraZeneca Muddies The Water As Mystic Fails  Merck  AZN
Q2 GDP, Big Oil, Merck, AbbVie, AAL  Air: Investing Action Plan  Merck  ABBV  American  XOM  CVX  investors
Biogen Witnessed High Revenue Growth in 2Q17  BIIB  NVS  SNY  Merck
 Merck added more on the pull back today.
Insightful remarks on Lynparza deal with  Merck.  AZN is selling future revenue for temp gains. Not smart. 
 VZ  Merck  DIS  Boeing keeping the Dow green. despite market selloff. 
Nice primer on IO combos  BMY  AZN  Merck  adamfeuerstein

via  statnews
Earnings 7/28 p/o:   AAL,  COG,  CVX,  SC,  CS,  ABBV,  GT,  Merck,  XOM,  WFT,  WY
 CELG spends 40% of revenue on R&D, a much larger share than peers  stocks  biotech  investing  PFE  JNJ  AMGN  Merck 
AstraZeneca Plunges Following Failed Lung Cancer Study  AZN Also  Merck  TEVA  BMY 
ICYMI:  AZN‚Äôs MYSTIC trial with Imfinzi goes bust, dents shares despite potential  8.5B  Merck Lynparza deal 
After MYSTIC miss,  AZN taps  Merck in  8.5B cancer deal 
 AZN  Merck  INCY  CLVS  TSRO:

How AstraZeneca Failed Not Once ‚Äî But Twice ‚Äî In Cancer Drugs:


 Merck reports before the open tomorrow, Estimize Consensus +0.01 EPS and -3.63M Revs compared to WS - 
 AZN,  Merck have big So SF real estate plans -> AstraZeneca inks  8.4B pact w Merck as key study fails, shares plunge 
Did the Checkpoint Inhibitor Bubble Just Burst?  AGEN  AZN  Merck  BMY
How AstraZeneca failed not once -- but twice -- in cancer drugs  AZN  Merck  BMY  INCY  CLVS  TSRO 
AstraZeneca beats, but stock dives on drug failure  AZN  Merck  BMY  CELG  ALXN  RHHBY 
 Biodefense  ONTX  AMGN  AOLS  Merck  BMY  SPPI  PSTI  SNY  NKTR Government Paying Closer Focus ( Radiation Treatment) 
 Google  FDX  Merck:

Ransomware Cost Surpasses  25 Million Mark:


Flip in the equities market as the red hots get crushed and the leaders are  VZ  Merck  T  DIS  MO  SBUX  APA  VIAB  FOX
Blowout --
UPDATED:  AZN inks  8.4B pact with  Merck as crucial MYSTIC study fails and shares plunge
 BMY

How  Merck's cancer blockbuster went from lab bench (to lab bench, to lab bench) to market: b‚Ä¶ ‚Ä¶
How  Merck's cancer blockbuster went from lab bench (to lab bench, to lab bench) to market: b‚Ä¶ 
I can't get over the irony of  Merck paying  1.6bn for a PARP inhibitor when it out-licensed one to  TSRO in 2012 that is now on the market.
May anyone with this disease get the best care available.  100's of failed meds.  Come on  fda  dcvax  NWBO  azn fa‚Ä¶ 
 AAL  CVX  XOM  Merck and more report before the market open tomorrow - get the 3 year stock price reaction histories‚Ä¶ 
 Merck  SQ  GNC Thurs Morn Trades Blog  
 CLVS up big on  AZN Lynparza deal with  Merck
 CNCR holding  Merck is scheduled to have its Q2 earnings call on Friday, July 28 at 8:00AM ET.‚Ä¶ 
 FANGS options heavy action:  FB,  AMZN,  Apple   AngieMiles w  FreeboardCap  Merck &  BMY 
 AstraZeneca and Merck  Merck Establish Strategic  Oncology Collaboration 
MUST READ: A profitable cannabis company:  GOOG  F  CMCSA  KO  BRK.B  MO  Merck  CMG  NVDA  EBoeingY
S&P100  Stocks Trend  GD  MSFT  CAT  FDX  PCLN  Intel  UPS  FOXA  Merck  CMCSA  HAL  DOW  DD  T  EMR  USB  ALL    
Dow  Stocks Trend  MSFT  CAT  Intel  Merck  DD  Boeing  CSCO  Apple  IBM  MCD  JPM  DIS  UNH  V  HD  TRV  MMM  AXP  GS    
I/O recap this week

 AZN MYSTIC fail in 1L NSCLC
 Merck KN-040 fail in HNSCC
 RHHBY axing OX40 and IDO
 AMGN "too many PD1/PD-L1 around"
Pharma Stocks to Watch for Earnings on Jul 28: ABBV, Merck  Merck  ABBV  BIIB
 ttph I think waiting to price makes sense.  Letting price settle. I'm guessing  8...we'll see!  Step up  mrk!
 PDRennert  BursatilBiotech Very hard to compare across trials. 2L setting different vs 1L. Design differences/cros‚Ä¶ 
Astrazeneca muddies the water as Mystic fails  AZN  Merck  PFE
 crtaylor81 Particularly since he has the 40% owner  Merck - Managing Director of Global Health - on the Board of Dir‚Ä¶ 
 Merck Looks ready for a short term bounce. Looking for breakout at 64.61 for a short term target of 75.47.  
How long can  ALXN rise on Soliris? 
 CELG  Merck  BIIB  PFI  MDT
Merck Top news - Jul 27th, 2017  Merck 
AstraZeneca plunges following failed lung cancer study  AZN  BMY  Merck  TEVA 
Bad news, good news:  AZN‚Äôs MYSTIC trial with Imfinzi goes bust;  Merck Lynparza deal worth up to  8.5B 
 Merck key break triggers at 63.64 fib slip
im going afk will not alert covers  Merck  GNC
 OP&GN has time but needs to get back over a  1 for Nasdaq listing requirements I doubt  Merck will let that happen or  PZE for that matter
 SNAP  NYT  Merck
I've been finding the best stocks trade using this site, check it outüíµ
 
The Pivotal Phase 3  KEYNOTE040 Trial with  KEYTRUDA in  HNSCC Did Not Meet Its Primary Endpoint  Merck 
 Merck reshortedf 63.91s
You're right  JacobPlieth . Here's  Merck (KEYNOTE 024) 
 AZN 
Merck KGaA given ‚Ç¨110.00 PT by Goldman Sachs Group, Inc. (The). neutral rating.  Merck  Merck
 AZN Does  azn has right to licence MEK to  Merck , versus  ARRY MEK  license to  BMY?
 Merck covered
Oh the irony.  Merck partners its PARPi (MK2512) to  TSRO in 2012 ( 7M uf). Now  1.6B uf gets them one back. 
 Merck sub .66 we might get a nice flush... carefull now its on vwap
The synergy with  AFMD and  PFE and  Merck  KGaA is deep. Watch  PFE acquire  AFMD and  Bavencio will play a huge role.
Not sure what to do with  Merck? Explore our  fundamental pros and cons.  
 Merck still in the trade here im short
 Options  maxpain chart for  Merck. Free options app 
 Merck added 64. SHORT
 Merck got a 64.15 average on my short...
 Merck SHORT 63.84
 AZN  Mystic shortfall is an  IO shake-up for  BMY & a bolster for  Merck &  RHHBY  biotech  lungcancer  NSCLC 
 ESPR    50-yet again!

P3 near 8 months too! If a b/o (w/  2B/yr rev   only 10% of potential market)   what price may ESPR sell?  Merck  AMGN
Hedging its bets after MYSTIC fail,  AZN inks  8.5B  oncology deal with  Merck 
sorry didnt alert plays today...but  Merck and  BMY both shorts
 AZN's Shares Decline in US  ~15% But Not A US Historic Tumble!  VRX  AGN  MYL  PRGO  NVS  BLUE  AMGN  MNK  AMGN‚Ä¶ 
AstraZeneca Is Sinking Today  AZN  PFE  BMY  Merck
UPDATED:  AZN inks  8.4B pact w/  Merck as crucial  MYSTICstudy fails & shares plunge  biotech  NSCLC  lungcancer 
 Merck Bristol-Myers shares slump after failed AstraZeneca drug trial 
Favs:  FB over 176,  ALXN over 140,  Merck over 65,  PYPL over 61,  TWTR under 17.30,  BMY under 53!
Good Morning : The Machine is watching  CAPR ,  SHOR ,  TOO ,  IDXG ,  DEO ,  FB ,  LPSN ,  MNGA ,  BUD ,  Merck ,  NOK ,  VZ ,  BTI ,  USLV
DAILY GAPPERS
July 27, 2017

Gap Up:  FB,  Merck,  VZ
Gap Down:  TWTR,  BMY,  BWLD
 earnings  premarket  StocksToWatch
Watchlist:  FB  TWTR  NVDA  Merck  CAPR  TOO  NUGT 
 daytrading  beatrader  StocksToWatch  StockTrading
 AZN  PFE  Merck:

AstraZeneca Takeover Chatter Bubbles Up Again After Massive ‚Ä¶:


Pharmalot.. Pharmalittle.. Good Morning.. AstraZeneca inks deal w/Merck as key trial bombs..  pharma  AZN  Merck
Anyone got  a breakdown for why the headline numbers for the 2 Parp deals today so different?  AZN  Merck  TSRO
 Merck Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures.... 
Recent  Merck technical alerts: Downside 200 DMA Break... 
We calculated 63-day Expected Return of  Merck for you: -0.5% 
 Merck downgraded to Neutral from Outperform at Credit Suisse
MUST READ: A profitable cannabis company:  Merck  DD  QCP  BUD  UGAZ  IRBT  LB  MORL  EWJ  RSO
3 Things In Biotech You Should Learn Today: July 27, 2017  BMY  Merck  THERF
 Mindthegap  FB  ALXN  Merck  AZN  BWLD  FFIV  GILD  TWTR  DEO  NTGR  CYH  BMY  TER
It is great time to buy or add  BMY. I think too many assumptions on  BMY and  Merck because of  AZN's failure.  stocks  trading  unvesting
Watching  CMCSA  FB  Merck  NTGR  ORLY  VZ higher.  ADP  BMY  BWLD  CYH  LVS  TER  WHR lower.  gaps  MajorLeagueStocks  trade
 Merck:

AstraZeneca‚Äôs late-stage trial failure sends its shares down 16% and ‚Ä¶:


PM Price &/or Vol Leaders (a/o 8:43am EST):  CAPR  SHOR  TOO  AXTI  GNC  FB  IDXG  ALXN  BUD  CPN  Merck  TEF  NOK 
Facebook Q2 earnings beat on all fronts. The  FB surge continues...

Others to watch  PYPL  ALXN  GNC  NTGR  XLNX  Merck.
 PFE  Merck  AMZN:

Samsung, Amazon ‚Äî Everyone Is Getting Into Pharmaceuticals:


Soriot believes  AZN partnership with  Merck will position Lynparza as leading PARP for backbone with PD-1/L1 combos
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Cancer Drug Combo Fails  AZN  BMY  Merck
Lots of news today...MYSTIC,  AZN  Merck partnership,  TSRO Takeda parternship, and on and on
AstraZeneca teams up with Merck to co-develop/co-commercialize cancer med Lynparza  AZN  Merck 
the  AZN multiverse

 MYSTIC bombs but  Merck deal is a stunner

ok then more coffee pls
 TSRO  CLVS  AZN  Merck CS Thoughts on PARP space announcements ‚ñ† Interesting news this morning in the PARP (cont) 
 BVZ_Investools Looked like 2  XLV (  ALXN,  Merck ) R up & 2  XLV (  BMY,  WST ) R down premarket today! Thx Coach f‚Ä¶ 
Roger Perlmutter's big bet. Fascinating story of  Merck 's development of   Keytruda 
 AZN  Merck:

AstraZeneca teams up with Merck to co-develop/co-commercialize ‚Ä¶:


AstraZeneca teams up with Merck to co-develop/co-commercialize cancer med Lynparza  premarket  AZN  Merck
Gainers in Premarket Trading  GNC  DEO  Merck  FB  TEF  NOK  PYPL  BTI  ABX  GILD  NUGT  MT  STO  JNUG  CMCSA  RACE 
 BMY down 5
 Merck up 5

Such a lovely sincro
 Premarket Top % Gainers:  CAPR 40%,  SHOR 28%  TROV  TOO  NAKD  MTBC  TK  GNC  AXTI  MYSZ  IDXG  FB  DEO  ALXN  BUD  Merck  CPN  TEF  NOK  VZ
 AZN,  Merck establish strategic oncology collaboration 
 Merck:

AstraZeneca shares plummet 16% on late-stage trial failure; Bristol ‚Ä¶:


WE WANT ACTION  fb  msft  cat  ibm  ge  gm  tsla  iep  brk  twtr  agn  pep  ibm  snap  jnj  mrk  vrx  myl  dis  f‚Ä¶ 
 AZN down 15% premarket on failed late-stage study on lung cancer candidate durvalumab;  Merck up 5.2% on improved prospects for Keytruda
What hope now for MYSTIC? My take on today's  AZN failure, via  EPVantage  BMY  Merck  RHHBY
And, so it was..  Merck and  CELG helping the family office... 
Details on the  BMY -  Merck  oncology deal: 
AstraZeneca's immune therapy combo for lung cancer fails, rewriting the cancer drug landscape:  AZN  BMY  Merck
AstraZeneca down 15% premarket on failed late-stage study on lung cancer candidate durvalumab; Merck up...  AZN  Merck
 ALXN reported 21% jump in revenue in 2Q17 to  912MM. The revenue ...alph.st/bf270b72

 alexionpharma  earnings‚Ä¶ 
 ALXN - Soliris sales in 2Q17 update 
 Merck  BIIB  JNJ  SYK  MDT  NVS  soliris  alexionpharma  stock  news
 ALXN reported 21% jump in revenue in 2Q17 to  912MM. The revenue reflected...
AstraZeneca down 15% premarket on failed late-stage study on lung cancer candidate durvaluma...  premarket  AZN  Merck
WE WANT ACTION!   fb  msft  cat  ibm  ge  gm  tsla  iep  brk  twtr  agn  pep  ibm  snap  jnj  mrk  vrx  myl  dis  f‚Ä¶ 
Merck & Company, Inc.  Merck Shares Sold by Sonata Capital Group Inc. 
 TRADING US Pre-Market Movers Gap Up  FB  ORLY  TAL  ALXN  EW  Merck  XLNX  BTI  PYPL  GILD  P&G  NOW  VZ 
Pre market Bio-Movers - Huge movements among Big pharma
 Merck +4,6%
 AZN -15%
 BMY -6,3%
 Merck Keynote-189 Keytruda+chemo Ph3 in 1L NSCLC should also read-out around same time

 mrk hot  bmy not
 Premarket Top % Gainers:  CAPR 68%,  TOO 16%,  TK  GNC  AXTI  DEO  MTBC  FB  BUD  CLF  Merck  CLF  TEF  TGP  NOK  TAL  PYPL  BTI  ABX  GILD
UPDATED: AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails and shares plunge
 AZN  Merck  BMY

Street Insider reporting Goldman raising  Merck PT to  74 from  70
 Merck JPM "Where this outcome represents a best case scenario, further strengthing the companys leadership position in 1L NSCLC)."
GS "We would expect  Merck to trade up ~5 points based on sentiment"
Merck  Merck +5 pct;  BMY -5 pct in light premarket trade;  AnkurBanerjee17, Sort of understood the connection, I'm b‚Ä¶ 
 Merck REPEAT/AstraZeneca and Merck Establish Strategic Oncology Collaboration... - 
 AZN lung cancer immunotherapy trial failure sends shares plunging ‚Äî> 
no doubt, you heard this already.  BMY  Merck
 Merck:

REPEAT/AstraZeneca and Merck Establish Strategic Oncology ‚Ä¶:


Leerink calls it: "While there r several key diffs..btwn MYSTIC & CM-227, unlikely to result in meaningfully diff outcomes".  AZN  BMY  Merck
 AZN -16%
 BMY -6.2%
 Merck +4.3%
As AZN immunotherapy lung cancer study Mystic fails to show AZN combo extended prog‚Ä¶ 
 AZN tapping  Merck to develop/commercialize Lynparza and selumetinib with Keytruda 
 Merck  Goldman: "We would expect Merck to trade up about 5 pts" ... after  AZN MYSTIC failure
 Premarket Top % Gainers:  TOO 16%,  TK 13%,  FHCO  DEO  DRYS  BUD  NOK  TAL  TGP  FB  Merck  TEF  BTI  NOK  DDR  PYPL  ABX  TTWR  RACE  JNUG
Weekly S&P100  Stocks Trend  DOW  DD  FDX  MSFT  CAT  FOXA  GD  PCLN  CMCSA  HAL  Intel  UPS  Merck  USB  EMR    
Weekly Dow  Stocks Trend  DD  MSFT  CAT  Intel  Merck  Boeing  CSCO  Apple  IBM  JPM  MCD  UNH  DIS  V  HD  TRV  AXP    
 Merck  AZN üëçüèªüëèüèªüëèüèªüôåüèª Establish Strategic Oncology Collaboration

Wow... I did not see this coming at all... 
Hill-Rom Holdings, Inc.  HRC EPS Estimated At  0.90; Numeric Investors Has Raised Merck & Co  Merck Holding By  33.... 
AstraZeneca, Merck & Co. enter cancer drug development deal focused on PARP inhibitor Lynparza  AZN  Merck
Playing for BIG stakes:
 AZN -15%
 Merck +4%
 BMY -6%

And some billions to be added to  Merck market cap 
Btw, Estimated  Earnings Per Share for  Merck is  1.07 it's 1.73% of the current price 
It's too early to matter and of course  BMY has earnings this morning, but so far preliminary trades are  Merck +4% on MYSTIC and  BMY -6%.
AstraZeneca and Merck Establish Strategic Oncology Collaboration  Merck
In for 25k thanks to you guys. Science real, on the cusp of something big and  Merck backing to boot!  OP&GN 
 JacobPlieth  Asthika What's the point of having PD-L1/CTLA4 combo if they can't expand PD-L1>=50% to 25%? Durvalum‚Ä¶ 
 Antony_SW11  marben100  mattbird55  DianaEPatterson  Financial_Orbit  AstraZeneca  JohnCendpts  jimmhk  asibiza1‚Ä¶ 
 BMY  PFE  Merck:

AstraZeneca Faces Major Setback Over Cancer Drugs:


 AZN partners with  Merck on development of olaparaib & selumetinib 
via  FT
 Dow  stocks  Merck Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  
As Astrazeneca's Mystic fails  AZN offers up  8.5bn oncology collaboration with  Merck as a consolation prize.
 Merck AstraZeneca lung cancer study fails in big setback for company 
 DrSManian  azn  mrk deal should take some of the sting away
AstraZeneca inks  8.4B pact with Merck as crucial MYSTIC study fails in first-line lung cancer
 AZN  Merck

 Merck AstraZeneca and Merck Establish Strategic Oncology Collaboration 
 AZN hits the wires (burying news?) with PR onslaught as Mystic fails at 1st cut - Tagrisso Flaura P3 hit,  Merck onc collab, Q2 results.
 Merck AstraZeneca and Merck Establish Strategic Oncology Collaboration... - 
And strikes a deal with  mrk with parp mek  azn
 AZN Also announcing oncology collaboration with  Merck to jointly develop & commercialize PARP inhibitor Lynparza &‚Ä¶ 
 Merck:

AstraZeneca and Merck Establish Strategic Oncology Collaboration:


Corning Exceeds Expectations on Optical and Gorilla Glass Strength  themotleyfool  stocks  Merck,  GLW,  PFE 
 freecozymyster1 thanks for follow! See Vista Partners  InvestingForLife  Dow30  V  MSFT‚Ä¶ 
 Merck 28-Jul-17 ATM Implied Volatility is up +42.7%. Straddle Implies a Move of ¬±2.5%. Earnings Jul 28 BMO. 
 BMY  RHHBY  AZN  PFE  Merck Cancer drug war heats up as Big Pharma squares off against Genentech‚Ä¶ 
 BMY files suit against Genentech  RHHBY.. separate suits against  AZN  PFE. Already settled with  Merck whom now pays royalties to BMS.
Price Returns vs Expected Daily Move  DVAX  BIIB  CELG  GILD  AZN  VRX  BMY  EW  PFE  CVS  Merck  AMGN‚Ä¶ 
